The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Damaj Bassam since 2012.
The trader's CIK number is 1478733.
At the time of the last reporting, Damaj Bassam was the President and CEO of Innovus Pharmaceuticals, Inc.. (stock ticker symbol INNV).
Also see all insider trading activities at Innovus Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | INNV | 667,247 | $253,581 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2012 | APRI | 2,260 | $6,138 | 0 | $0 | 0 | $0 |
1. Innovus Pharmaceuticals, Inc. (INNV)
2. Apricus Biosciences, Inc. (APRI)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-06-12 | INNV | Buy | 416,841 | .32 | 134,639 |
| 2013-02-02 | INNV | Buy | 250,406 | .47 | 118,942 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-08-21 | APRI | Buy | 760 | 2.77 | 2,105 |
| 2012-08-20 | APRI | Buy | 1,500 | 2.69 | 4,033 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Damaj Bassam (President and CEO of Innovus Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.